Management Implications of Evaluating the N2 and N3 Neck After Organ Preservation Therapy

Abstract

The discovery of proliferating cancer cells in 3 of 17 irradiated specimens (18%) supports the practice of planned neck dissection after primary radiotherapy for patients with pretherapeutic N2+ metastatic disease.